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Purpose: In some patients with an implantable cardioverter defibrillator (ICD), multi-
ple episodes of electrical storm (ES) can occur. We assessed the prevalence, features, 
and predictors of ES in patients with ICD. Materials and Methods: Eighty-five pa-
tients with an ICD were analyzed. ES was defined as the occurrence of two or more 
ventricular tachyarrhythmias within 24 hours. Results: Twenty-six patients experi-
enced at least one ES episode, and 16 patients experienced two or more ES episodes. 
The first ES occurred 209 ± 277 days after ICD implantation. In most ES cases, the 
index arrhythmia was ventricular tachycardia (65%). There were no obvious etiologic 
factors at the onset of most ES episodes (57%). More patients with a structurally nor-
mal heart (p = 0.043) or ventricular fibrillation (VF) as the index arrhythmia (p = 
0.017) were in the ES-free group. Kaplan-Meier estimates and a log-rank test showed 
that patients with nonischemic dilated cardiomyopathy (DCMP) (log-rank test, p = 
0.016) or with left ventricular ejection fraction < 35% (p = 0.032) were more likely to 
experience ES, and that patients with VF (p = 0.047) were less affected by ES. Cox 
proportional hazard regression analysis showed that nonischemic DCMP correlated 
with a greater probability of ES (hazard ratio, 3.71; 95% confidence interval, 1.16-
11.85; p = 0.027). Conclusion: ES is a common and recurrent event in patients with 
an ICD. Nonischemic DCMP is an independent predictor of ES. Patients with VF or 
with a structurally normal heart are less likely to experience ES.
Key Words:    Implantable cardioverter defibrillators, ventricular tachycardia, ven-
tricular fibrillation
INTRODUCTION
Sudden cardiac death remains one of the leading causes of death.1 An implantable 
cardioverter defibrillator (ICD) prolongs the lifespan of patients when used for pri-
mary or secondary prophylaxis of sudden cardiac death.2-4 Patients with an ICD 
can develop a so-called electrical storm (ES) during follow-up.5-8 Several studies 
have assessed the prevalence and possible predictors of ES in patients with an 
ICD,5,8-13 but there are insufficient data about ES in patients with an ICD and espe-Electrical Storm and ICD
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could be programmed to provide different therapies to 
tachyarrhythmias in up to three heart rate zones. In each 
therapy zone, bursts of antitachycardia pacing (APT), car-
dioversion, or defibrillation could be delivered. Although a 
variety of algorithms exist, APT was usually programmed 
to be delivered at a rate that is slightly faster (at a cycle 
length 10 to 12 percent shorter) than the rate of the detect-
ed tachycardia. Devices were often programmed to deliver 
synchronized cardioversion for tachyarrhythmias in this 
range (heart rate below 160 or 180 beats/min), and usually 
programmed to deliver unsynchronized shocks for very 
rapid ventricular arrhythmias (heart rate > 180 or 200 
beats/min).
Follow-up 
After ICD implantation, the patients were followed up in 
our outpatient ICD clinic. The devices were interrogated, 
and the complete set of data (including intracardiac elec-
trograms) was recorded. Blood samples, echocardiogra-
phy, coronary angiography, reprogramming of ICD, or ad-
justment of drug therapy were performed as needed 
according to the events recorded and factors deemed caus-
ative.
Definitions 
For this study, we defined ES as the occurrence of two or 
more ventricular tachyarrhythmia within 24 hours, which 
need immediate electrical therapy (ATP and/or shock) to 
be terminated, separated by a period of sinus rhythm.9,15-17 
We divided patients into two groups according to occur-
rence of ES. Individual demographic and clinical data 
were entered into a continually updated database. Multiple 
device activation from supraventricular tachyarrhythmias 
or other factors not related to ventricular tachyarrhythmic 
events (defined as “inappropriate therapy”), as judged by 
the clinical picture and analysis of stored electrograms, 
were excluded.
Statistical analysis 
The data are expressed as mean ± standard deviation or as 
percentages. Differences in the frequency of characteristics 
were assessed by the two independent-samples tests for 
continuous variables. Chi-square statistics (or Fisher’s exact 
test if applicable) were used to analyze discrete variables. 
We used survival analysis method to investigate the rela-
tionship between the significance of clinical outcomes and 
ES. Cumulative incidence of clinical outcomes was esti-
cially about the predictors of ES.5,10 We examined the inci-
dence, features, and timing of the occurrence and predictors 




The medical records of 85 patients with an ICD implanted 
from October 1999 to April 2009, who were treated at 
Samsung Medical Center in Seoul, Korea, were analyzed 
retrospectively. All patients gave written informed consent 
for the procedure of ICD implantation. Of these patients, 
any patient who had had one or more episode of ES was in-
cluded in the study population. All arrhythmias detected 
during an ES episode were also reviewed. The study was 
approved by the regional committee for ethnics in medical 
research.
Indication of ICD implantation 
The indication for ICD implantation was defined as second-
ary prevention in patients who had experienced aborted 
sudden cardiac death, sustained ventricular tachyarrhyth-
mia, or in the context of presumed tachyarrhythmic synco-
pal attacks.14 The indication for ICD implantation in all oth-
er patients was categorized as primary prevention.
Implanted ICDs 
The ICDs were manufactured by St. Jude Medical, Inc. (n 
= 45), Medtronic, Inc. (n = 38), or Guidant Corp. (n = 2). 
Single chamber devices were implanted in 77 patients, and 
double chamber devices in 8 patients. A total of 94 proce-
dures were performed in these 85 patients. 
Ventricular tachyarrhythmia episodes were appropriately 
detected by the device. Some devices recorded templates of 
the ventricular electrogram during sinus rhythm. During a 
tachyarrhythmia, the device compared the electrograms 
during the tachycardia to the baseline. Mean detection cut-
off for slow ventricular tachycardia (VT) was 380 millisec-
onds (159 beats/min), and 332 milliseconds (181 beats/
min) for fast VT, and 297 milliseconds (202 beats/min) for 
ventricular fibrillation (VF). Also, 5 patients were diag-
nosed to have VT, based on surface electrocardiogram dur-
ing hospitalization. 
We often attempted to tailor therapies based upon the re-
sults of electrophysiologic study and/or a patient’s arrhyth-
mia history (patient-specific tailored programming). ICDs Pil Sang Song, et al.
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RESULTS
Clinical and laboratory characteristics of ICD patients
Eighty-five patients with an ICD were followed for a mean 
of 861 ± 715 days. We compared the baseline characteristics 
between patients with ES (n = 26, 31%) and without ES (n 
= 59, 69%) during follow-up. The mean follow-up period 
mated by the Kaplan-Meier method, and differences were 
assessed with the log-rank test for ES. We used Cox pro-
portional hazard regression analysis with the forward selec-
tion method to identify precipitating factors. All tests of sta-
tistical significance were two-tailed, and a p value of 0.05 
was considered significant. Statistical analyses were per-
formed using SPSS statistical software (version 15.0; SPSS 
Inc., Chicago, IL, USA).
Table 1. Comparison of Patients with and without Electrical Storm
Electrical storm
p value
Yes (n = 26) No (n = 59)
Age (yrs) 56 ± 15 51 ± 17 0.283
Male 22 (85%) 52 (88%) 0.730
Clinical history
    Hypertension 11 (42%) 19 (32%) 0.369
    Diabetes mellitus 1 (4%)   9 (15%) 0.166
    Atrial fibrillation   7 (27%) 18 (31%) 0.738
    Syncope 16 (62%) 45 (76%) 0.164
    Aborted arrest   7 (27%) 25 (42%) 0.176
Structural heart disease
    Coronary artery disease 11 (42%) 23 (39%) 0.767
    Nonischemic DCMP   4 (15%)   7 (12%) 0.730
    None (structurally normal heart)   4 (15%) 23 (39%) 0.031
Concomitant medications
    β-blocker 19 (73%) 37 (63%) 0.353
    ACE inhibitors or ARB 15 (58%) 35 (59%) 0.888
    Amiodarone    3 (12%) 2 (3%) 0.141
QRS duration ≥ 120 (ms) 10 (38%) 15 (25%) 0.224
LVEF < 35% 10 (38%) 15 (25%) 0.243
Index arrhythmia
    Ventricular tachycardia 22 (85%) 42 (71%) 0.225
    Ventricular fibrillation   5 (19%) 27 (46%) 0.017
Indication for ICD implantation 0.133
    Primary prevention 1 (4%)   9 (15%)
    Secondary prevention 25 (96%) 50 (85%)
Type of ICD 0.656
    ICD-single chamber 23 (88%) 54 (92%)
    ICD-dual chamber 3 (12%) 5 (8%)
ICD manufactured by 0.657
    St. Jude 15 (58%) 30 (51%)
    Medtronic 10 (38%) 28 (47%)
    Guidant 1 (4%) 1 (2%)
Follow-up duration (days) 990 ± 742 804 ± 702 0.262
Time to first ES (days) 209 ± 277
Time to second ES from first ES (days) 251 ± 362
DCMP, dilated cardiomyopathy; ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; LVEF, left ventricular ejection 
fraction; ICD, implantable cardioverter defibrillator. ES, electrical storm.Electrical Storm and ICD
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with ATP alone (n = 55, 48%) or a combination of shocks 
and ATP (n = 32, 28%). In most ES cases, the recorded in-
dex arrhythmia was ventricular tachycardia (VT, 65%). VF 
and both VT and VF occurred in 11% and 24% of the ES 
episodes, respectively. One patient experienced a storm im-
mediately following ICD implantation (on the same day). 
Details of the clinical characteristics and management of 
the patients with ES are presented in Table 2. Three patients 
have had heart transplants; two in the ES group and one in 
the ES-free group. Nine deaths occurred, five in the ES 
group and four in the ES-free group. 
Etiologic factors of ES
No obvious etiologic factor was evident at the onset of the 
was 990 ± 742 days for the patients with ES, and 804 ± 702 
days for those without ES. The clinical characteristics in 
both groups were similar, except for two clinical characteris-
tics: a structurally normal heart and VF as the index arrhyth-
mia for ICD implantation, which were more frequent in the 
ES-free patients (Table 1). Twenty-six patients experienced 
at least one ES episode. Overall, 115 ES episodes were re-
corded (median, 2 ES per patient; range, 1-45), and 16 
(62%) patients in the ES group experienced two or more 
ES episodes. ES occurred first at a mean of 209 ± 277 days 
after ICD implantation, and the mean duration between the 
first and second ES occurrence was 251 ± 326 days. Shocks 
alone were used to treat 28 of the 115 initial ES episodes (n 
= 28, 24%), and the remaining 87 episodes were treated 
Table 2. Clinical and Laboratory Characteristics of Patients Presenting with Electrical Storm
Patient 
no.










  1 M 73 CAD Secondary VT 27 1,000 10
  2 M 70 CAD Secondary VT 39   67   3
  3 F 26 SNH Secondary VT 72 276   1
  4 M 81 CAD Secondary VT 38 186   4
  5 M 69 CAD Secondary VT 30   31   1
  6 M 54 NIDCMP Secondary VT 29     9   5
  7 M 73 ARVD Secondary VT 58 950   1
  8 M 45 SNH Secondary VF 66   43   4
  9 M 77 CAD Secondary VT 35 262   1
10 M 58 CAD Secondary VT 25     0 45
11 M 58 NIDCMP Secondary VT 21   60   2
12 M 39 HCMP Secondary VF 66 672   2
13 M 46 CAD Secondary VT 37   91   1
14 M 49 NIDCMP Secondary VT 29   17   3
15 M 35 SNH Secondary VF 65   16   1
16 M 64 ARVD Primary VT 54 371   2
17 M 59 CAD Secondary VT 30 227   1
18 F 72 NIDCMP Secondary VT 32 100   2
19 F 37 HCMP Secondary VT 76   78   2
20 M 47 HCMP Secondary VT 15   14 13
21 M 61 HCMP Secondary VT 70     3   1
22 M 42 HCMP Secondary VT 53   48   2
23 M 35 SNH Secondary VT 59 162   2
24 M 47 HCMP Secondary VT 39 138   4
25 F 72 CAD Secondary VT 25 147   1
26 M 72 CAD Secondary VF 39 475   1
LVEF, left ventricular ejection fraction; ES, electrical storm; CAD, coronary artery disease; SNH, structurally normal heart; NIDCMP, 
nonischemic dilated cardiomyopathy; ARVD, arrhythmogenic right ventricular dysplasia; HCMP, hypertrophic cardiomyopathy; VT, ven-
tricular tachycardia; VF, ventricular fibrillation.Pil Sang Song, et al.
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nonischemic DCMP as the underlying heart disease (log-
rank test, p = 0.016) or with left ventricular ejection fraction 
(LVEF) < 35% (log-rank test, p = 0.032) were more likely to 
experience ES, and that patients with VF as the index ar-
rhythmia (log-rank test, p = 0.047) were less affected by ES 
(Table 3). The Cox proportional hazard regression analysis 
showed that only nonischemic DCMP as the underlying 
heart disease (hazard ratio, 3.71; 95% CI: 1.16-11.85; p = 
0.027) was significantly and independently associated with a 




Our study reveals several findings about the occurrence of 
ES in ICD patients. Twenty-six (31%) patients who under-
went ICD placement experienced at least one ES episode, 
and a substantial proportion (62%) of patients experienced 
repeated ES episodes. Most ES episodes involved VT and 
occurred usually without obvious etiologic factors (57%). 
Our data suggest that patients with nonischemic DCMP as 
the underlying heart disease are at greater risk for ES. The 
storm in 65 (57%) ES episodes. Worsening congestive 
heart failure was evident as an etiologic factor in 19 (17%) 
cases. Fifteen (13%) storms occurred in the context of other 
medical illnesses. Six (5%) ES episodes were associated 
with either non-compliance or adjustment of antiarrhyth-
mics or other medications. Three (3%) ES episodes occurred 
during and around periods of excess alcohol consumption, 
and four (3%) storms followed periods of unusual physical 
or emotional stress. One ES episode was probably caused 
by hyperkalemia (5.9 mmol/L) and one ES episode was 
caused by malposition of an ICD lead (Fig. 1).
Predictors of ES
Chi-square tests showed that more patients with a structural-
ly normal heart (p = 0.043) or VF as the index arrhythmia 
for ICD (p = 0.017) were in the ES-free group. The odds ra-
tios of a structurally normal heart and VF as the index ar-
rhythmia for ICD were 0.285 [95% confidence interval (CI): 
0.087-0.933] and 0.273 (95% CI: 0.091-0.824), respectively. 
These data suggest that having VF as the index arrhythmia 
or a structurally normal heart seemed to protect against ES. 
We intended to find predictive factors for ES. The Kaplan-
Meier estimate and log-rank test showed that patients with 
Table 3. Survival Analysis of the Univariate Predictors of Electrical Storm (Kaplan-Meier Estimate and Log-
Rank Test)
Covariates Median survival (days) Chi-square Significance level
Nonischemic DCMP 5.79 0.016
    No 1,638
    Yes 1,160
LVEF 4.60 0.032
    ≥ 35% 1,638
    < 35% 1,292
VF as index arrhythmia 3.94 0.047
    No 1,441
    Yes 1,974
DCMP, dilated cardiomyopathy; LVEF, left ventricular ejection fraction; VF, ventricular fibrillation.
Fig. 1. Presumed etiologic factors of electrical storm. Cause assignment was made by the physician at the time the electrical storm oc-
curred. CHF, congestive heart failure.
57%




  Worsening of CHF
  Other medical illness
  Medication change or 
         non-compliance
  Excess alcohol
  Physical or emotional stress
  OthersElectrical Storm and ICD
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tients, for an overall incidence of 48%.
Limitations of this study
Our study is limited by the relatively small sample size 
comprising a selected patient population and the retrospec-
tive, observational single-center design. Our results should 
be confirmed in a large, prospective study.
Conclusions
ES is a relatively frequent complication that may occur at 
any time after ICD implantation and can become a recur-
rent event in ICD recipients. Our data provide evidence to 
indicate that nonischemic DCMP as the underlying heart 
disease is associated with an increased risk of ES, and that 
patients with VF as the index arrhythmia or a structurally 
normal heart are less likely to experience ES.
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